Clinical Trials Browser

OTHER × Vorinostat × Breast × Clear all

NCT03742245 2026-03-16

Olaparib in Combination With Vorinostat in Patients With Relapsed/Refractory and/or Metastatic Breast Cancer

Phase 1 Active not recruiting

Breast Neoplasms, Neoplasm Metastasis, Recurrence

NCT00838929 2025-05-04

Study of the Combination of Vorinostat and Radiation Therapy for the Treatment of Patients With Brain Metastases

Phase 1 Completed

17 enrolled 8 charts

BreastCNSThoracic

Brain Neoplasms, Breast Neoplasms, Lung Neoplasms

NCT03878524 2024-03-04

Serial Measurements of Molecular and Architectural Responses to Therapy (SMMART) PRIME Trial

Phase 1 Terminated

BreastClassical hematologyGastrointestinalGenitourinaryLymphoidMyeloidOther hematologic neoplasmPlasma cell

Anemia, Blast Crisis, Breast Neoplasms, Hodgkin Disease, Lymphoma, Non-Hodgkin, Multiple Myeloma, Myelodysplastic Syndromes, Myeloproliferative Disorders, Neoplasm Metastasis, Pancreatic Neoplasms, Prostatic Neoplasms, Thrombocytosis, Leukemia, Lymphocytic, Chronic, B-Cell, Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Leukemia, Myeloid, Accelerated Phase, Leukemia, Myeloid, Chronic-Phase, Leukemia, Myeloid, Acute, Leukemia, Myelomonocytic, Chronic, Hematologic Neoplasms, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Myelodysplastic-Myeloproliferative Diseases, Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative, Primary Myelofibrosis

NCT04190056 2023-08-31

Pembrolizumab and Tamoxifen With or Without Vorinostat for the Treatment of Estrogen Receptor Positive Breast Cancer

Phase 2 Terminated

1 enrolled 4 charts

Anatomic Stage IV Breast Cancer AJCC v8

NCT00574587 2020-10-14

Trial for Locally Advanced Breast Cancer Using Vorinostat Plus Chemotherapy

Phase 1/2 Completed

55 enrolled 10 charts

Breast Neoplasms

NCT02395627 2020-07-07

Reversing Therapy Resistance With Epigenetic-Immune Modification

Phase 2 Terminated

38 enrolled 18 charts

Breast Neoplasms

NCT01720602 2020-01-07

Vorinostat in Treating Patients With Stage IV Breast Cancer Receiving Hormone Therapy

Phase NA Completed

15 enrolled 10 charts

Breast Neoplasms, Breast Neoplasms, Male

NCT01118975 2019-11-13

GCC 0845:Vorinostat and Lapatinib in Advanced Solid Tumors and Advanced Breast Cancer to Evaluate Response and Biomarkers

Phase 1/2 Terminated

12 enrolled 6 charts

Breast Neoplasms, Neoplasm Metastasis

NCT01084057 2019-11-05

Ixabepilone and Vorinostat in Treating Patients With Metastatic Breast Cancer

Phase 1 Completed

Breast Neoplasms, Breast Neoplasms, Male

NCT01153672 2019-09-06

Vorinostat in Treating Patients With Stage IV Breast Cancer Receiving Aromatase Inhibitor Therapy

Phase NA Completed

8 enrolled 10 charts

Breast Neoplasms, Breast Neoplasms, Male

NCT00788112 2017-08-07

Vorinostat in Treating Women With Ductal Carcinoma in Situ of the Breast

Phase 1 Completed

Breast Neoplasms, Carcinoma, Intraductal, Noninfiltrating

NCT00719875 2017-03-03

HDAC Inhibitor Vorinostat (SAHA) With Capecitabine (Xeloda) Using a New Weekly Dose Regimen for Advanced Breast Cancer

Phase 1 Completed

Advanced Breast Cancer

NCT00365599 2014-11-21

Phase II Trial of SAHA & Tamoxifen for Patients With Breast Cancer

Phase 2 Completed

43 enrolled 8 charts

Breast Neoplasms, Neoplasm Metastasis, Bulbo-Spinal Atrophy, X-Linked

NCT01695057 2014-01-28

Vorinostat Before Surgery in Treating Patients With Triple-Negative Breast Cancer

Phase NA Withdrawn

Breast Neoplasms, Triple Negative Breast Neoplasms

NCT00416130 2013-12-10

Clinical Trial of SAHA in Patients With Breast Cancer

Phase 1/2 Unknown

Breast Neoplasms

NCT01194427 2013-05-17

A Study of Vorinostat and Tamoxifen in Newly Diagnosed Breast Cancer

Phase 2 Terminated

2 enrolled 3 charts

Breast Neoplasms